로딩 중…
지수 로딩 중…
제이엘케이
322510· KOSDAQ· Health Care· Health Care Equipment & Services
₩4,800+2.24%
2026-11-02
Financials
Valuation Metrics
제이엘케이's Market Cap is ₩1235B. At end of 2025 it was ₩1430B. Ranked #1092 of 2,410 in KR market (top 45%), #564 of 1,631 on KOSDAQ (top 35%), #39 of 94 in Health Care Equipment & Services (top 41%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 123.48B KRW | KR#1,092/2,410 Sec#39/94 |
| Revenue | 2.72B KRW | KR#2,365/2,410 Sec#93/94 |
| Net Income | -15.13B KRW | KR—/2,410 Sec—/94 |
| Total Assets | 69.51B KRW | KR#2,010/2,410 Sec#65/94 |
| Net Assets | 34.70B KRW | KR#2,123/2,410 Sec#75/94 |
| Employees | 83 | KR#1,782/2,410 Sec#69/94 |
| Value | ||
| P/B | 3.56x | KR#2,183/2,410 Sec#80/94 |
| P/S | 45.34x | KR#2,361/2,410 Sec#92/94 |
| Profitability | ||
| ROE | -43.58% | KR#2,247/2,410 Sec#82/94 |
| ROA | -21.76% | KR#2,249/2,410 Sec#79/94 |
| Op. Margin | -501.82% | KR#2,353/2,410 Sec#91/94 |
| Revenue Growth | 4.31% | KR#1,231/2,410 Sec#64/94 |
| Financial Health | ||
| Debt Ratio | 100.28% | KR#1,555/2,410 Sec#77/94 |
| Total Debt | 53.10B KRW | KR#980/2,410 Sec#24/94 |
| Cash | 4.85B KRW | KR#2,012/2,410 Sec#70/94 |
| Current Ratio | 1.85x | KR#947/2,410 Sec#57/94 |
| Performance | ||
| 1Y Return | -12.57% | KR#977/2,410 Sec#23/94 |
| 1M Return | -6.61% | KR#791/2,410 Sec#29/94 |
| From 52W High | -47.88% | KR#1,091/2,410 Sec#39/94 |
| 1Y MDD | -57.61% | KR#1,299/2,410 Sec#46/94 |
| Trading | ||
| Volume | 47,287 shares | KR#950/2,410 Sec#33/94 |
| Trading Value | 226.4M KRW | KR#1,083/2,410 Sec#45/94 |
| Foreign Own. | 1.65% | KR#1,768/2,410 Sec#65/94 |
| Per Share | ||
| EPS | -588 KRW | KR—/2,410 Sec—/94 |
| BPS | 1,349 KRW | KR#2,229/2,410 Sec#83/94 |
Company Info
Established in 2014 and listed on KOSDAQ in 2019, JLK is a medical artificial intelligence solution specialized enterprise. Leveraging AI technology, the company offers early disease diagnosis, interpretation support, and lesion detection services through the analysis of medical images such as MRI, CT, and X-Ray. JLK is commercializing MEDIHUB STROKE and Cancer Solution, and is pursuing global expansion with 76 worldwide permits and approvals. The company is headquartered in Cheongju-si, Chungcheongbuk-do.